AEP
45
5
IBM
53
2
FCX
44
4
UPS
51
6
EMR
57
7
QRVO
16
-6
HD
43
8
FMC
23
7
JNPR
59
3
WMB
58
3
KO
44
2
XOM
33
3
IR
46
3
MMM
35
3
ADT
12
2
JCI
44
7
MHK
25
5
CPB
24
2
SHW
42
5
VRSK
54
2
AEP
45
5
IBM
53
2
FCX
44
4
UPS
51
6
EMR
57
7
QRVO
16
-6
HD
43
8
FMC
23
7
JNPR
59
3
WMB
58
3
KO
44
2
XOM
33
3
IR
46
3
MMM
35
3
ADT
12
2
JCI
44
7
MHK
25
5
CPB
24
2
SHW
42
5
VRSK
54
2
Financhill
Back

Maravai LifeSciences Holdings 10K Form

Sell
15

MRVI
Maravai LifeSciences Holdings

Last Price:
$5.38
Seasonality Move:
12.9%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MRVI News And Ratings

See the #1 stock for the next 7 days that we like better than MRVI

MRVI Financial Statistics

Sales & Book Value

Annual Sales: $288.9M
Cash Flow: $3.5M
Price / Cash Flow: 0
Annual Sales: $2.44
Price / Book: 2.21

Profitability

EPS (TTM): -1.64000
Net Income (TTM): $-224.7M
Gross Margin: $140.2M
Return on Equity: -29.18%
Return on Assets: -14.17%

Maravai LifeSciences Holdings Earnings Forecast

Key Maravai LifeSciences Holdings Financial Ratios

  • The Gross Profit Margin over the past 6 years for MRVI is 48.52%.
  • The Selling, General & Administrative Expenses for MRVI have been equal to 52.39% of Gross Profit Margin.
  • The Research & Development expenses have been 5.98% of Revenue.
  • The Interest Expense is -38.56% of Operating Income.
  • The Net Earning history of MRVI is -41.19% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 3 years.

Maravai LifeSciences Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: MRVI
Website: maravai.com

Debt

Debt-to-Equity Ratio: 1.51
Current Ratio: 10.74
Quick Ratio: 9.6

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MRVI Technical Analysis vs Fundamental Analysis

Sell
15
Maravai LifeSciences Holdings (MRVI) is a Sell

Is Maravai LifeSciences Holdings a Buy or a Sell?